Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study page adds an Amyloidosis topic and a Genetic and Rare Diseases Information Center resource, along with a new citation for a 2026 JAMA Cardiol article. A previously listed JAMA Cardiol article reference was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check32 days agoChange DetectedShow glossary option added; Brno-střed, Czechia added as a location. QC-related text updated (Last Update Submitted that Met QC Criteria) and the revision shows v3.4.0, with capitalization changes for No FEAR Act Data.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded a citation for a plain-language review of ATTRibute-CM by Gillmore et al. (Future Cardiol. 2025) to Publications. Removed the older online-ahead-of-print citation and updated the entry to Revision: v3.3.4.SummaryDifference0.1%

- Check68 days agoChange DetectedLocations section expanded with numerous new sites across the US, Canada, Europe, and other regions, and some sites were removed. This changes the set of enrollment locations for the study.SummaryDifference2%

- Check89 days agoChange DetectedA new publication citation by Dasgupta et al. was added to Publications. The existing online-ahead-of-print entry was removed and the revision/version updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.